{"disease":{"id":"hepatocellular-carcinoma-patients","name":"hepatocellular carcinoma patients"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01796145","title":"Fibroscan Study in HCC","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":207,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT07395635","title":"Phase II Trial of Immunonutrition in Hepatectomy","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Tata Memorial Centre","has_results":false},{"nct_id":"NCT05846035","title":"Paraneoplastic Syndrome in Hepatocellular Carcinoma Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Sohag University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}